Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Endometrial Neoplasms × atezolizumab × Clear all

Phase

Status

Recruiting 3 Active not recruiting 3 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 39 Neoplasms 20 Melanoma 15 Urinary Bladder Neoplasms 14 Breast Neoplasms 14 Triple Negative Breast Neoplasms 13 Carcinoma, Transitional Cell 13 Carcinoma, Hepatocellular 11 Ovarian Neoplasms 10 Small Cell Lung Carcinoma 9 Neoplasm Metastasis 9 Colorectal Neoplasms 9 Uterine Cervical Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Solid Tumors 5 Lymphoma 5 Head and Neck Neoplasms 5 Esophageal Neoplasms 5 Carcinoma, Renal Cell 5 Stomach Neoplasms 4 Lung Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Kidney Neoplasms 3 Biliary Tract Neoplasms 3 Solid Tumor 2 Solid Cancers 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Multiple Myeloma 2

Interventions

Paclitaxel 28 Carboplatin 23 pembrolizumab 15 Surveys and Questionnaires 11 temsirolimus 10 Radiotherapy 9 Doxorubicin 9 Cisplatin 9 Docetaxel 8 Nivolumab 7 Metformin 7 Early Intervention, Educational 7 Bevacizumab 7 lenvatinib 6 Sirolimus 6 Radiation 6 Counseling 6 olaparib 5 Topotecan 5 Therapeutics 5 Psychiatric Rehabilitation 5 Methods 5 Letrozole 5 Ipilimumab 5 Indocyanine Green 5 Gemcitabine 5 Chemotherapy, Adjuvant 5 ridaforolimus 4 Trastuzumab 4 Taxes 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03603184 2025-05-09

AtTEnd

Mario Negri Institute for Pharmacological Research

Phase 3 Completed

Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡